These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10549447)

  • 1. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
    Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
    Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception with progestogens and progesterone during lactation.
    Shaaban MM
    J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial.
    Massai R; Quinteros E; Reyes MV; Caviedes R; Zepeda A; Montero JC; Croxatto HB
    Contraception; 2005 Nov; 72(5):352-7. PubMed ID: 16246661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.
    Roy M; Hazra A; Merkatz R; Plagianos M; Alami M; Gaur LN; Aruldas K; Sussman H; Variano B; Sitruk-Ware R;
    Contraception; 2020 Sep; 102(3):159-167. PubMed ID: 32360666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
    Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
    Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
    Coutinho EM; Athayde C; Dantas C; Hirsch C; Barbosa I
    Contraception; 1999 Feb; 59(2):115-22. PubMed ID: 10361626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
    Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
    Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone vaginal ring for contraceptive use during lactation.
    Nath A; Sitruk-Ware R
    Contraception; 2010 Nov; 82(5):428-34. PubMed ID: 20933116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
    Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility regulation in nursing women. II. Comparative performance of progesterone implants versus placebo and copper T.
    Croxatto HB; Díaz S; Peralta O; Juez G; Casado ME; Salvatierra AM; Durán E
    Am J Obstet Gynecol; 1982 Sep; 144(2):201-8. PubMed ID: 7114130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
    Hall P; Bahamondes L; Diaz J; Petta C
    Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring.
    Díaz S; Jackanicz TM; Herreros C; Juez G; Peralta O; Miranda P; Casado ME; Schiapacasse V; Salvatierra AM; Brandeis A
    Contraception; 1985 Dec; 32(6):603-22. PubMed ID: 3912105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.